These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27461636)

  • 1. rs61764370 polymorphism of Kras and risk of cancer in Caucasian population: A meta-analysis.
    Zhang SY; Shi J
    J Cancer Res Ther; 2016; 12(2):699-704. PubMed ID: 27461636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis.
    Ying HQ; Wang F; He BS; Pan YQ; Gao TY; Xu YQ; Li R; Deng QW; Sun HL; Wang SK
    Onco Targets Ther; 2014; 7():1487-96. PubMed ID: 25210463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Role of the KRAS Gene Polymorphism LCS6 (rs61764370) in Iraqi Women with Ovarian Cancer.
    Ghazi Jumaa M
    Arch Razi Inst; 2022 Feb; 77(1):205-211. PubMed ID: 35891756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for genetic association with the let-7 microRNA-binding site or other common KRAS variants in risk of endometriosis.
    Luong HT; Nyholt DR; Painter JN; Chapman B; Kennedy S; Treloar SA; Zondervan KT; Montgomery GW
    Hum Reprod; 2012 Dec; 27(12):3616-21. PubMed ID: 23010532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between rs61764370, rs9266, and rs140080026 polymorphisms of the KRAS gene and breast cancer risk in a Mexican population.
    Gallegos-Arreola MP; García Verdín PM; Magaña-Torres MT; Figuera LE; Zúñiga-González GM; Rosales-Reynoso MA; Gómez-Meda BC; Puebla-Pérez AM
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6454-6464. PubMed ID: 34787849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
    Pharoah PD; Palmieri RT; Ramus SJ; Gayther SA; Andrulis IL; Anton-Culver H; Antonenkova N; Antoniou AC; Goldgar D; ; Beattie MS; Beckmann MW; Birrer MJ; Bogdanova N; Bolton KL; Brewster W; Brooks-Wilson A; Brown R; Butzow R; Caldes T; Caligo MA; Campbell I; Chang-Claude J; Chen YA; Cook LS; Couch FJ; Cramer DW; Cunningham JM; Despierre E; Doherty JA; Dörk T; Dürst M; Eccles DM; Ekici AB; Easton D; ; Fasching PA; de Fazio A; Fenstermacher DA; Flanagan JM; Fridley BL; Friedman E; Gao B; Sinilnikova O; ; Gentry-Maharaj A; Godwin AK; Goode EL; Goodman MT; Gross J; Hansen TV; Harnett P; Rookus M; ; Heikkinen T; Hein R; Høgdall C; Høgdall E; Iversen ES; Jakubowska A; Johnatty SE; Karlan BY; Kauff ND; Kaye SB; Chenevix-Trench G; ; Kelemen LE; Kiemeney LA; Kjaer SK; Lambrechts D; Lapolla JP; Lázaro C; Le ND; Leminen A; Leunen K; Levine DA; Lu Y; Lundvall L; Macgregor S; Marees T; Massuger LF; McLaughlin JR; Menon U; Montagna M; Moysich KB; Narod SA; Nathanson KL; Nedergaard L; Ness RB; Nevanlinna H; Nickels S; Osorio A; Paul J; Pearce CL; Phelan CM; Pike MC; Radice P; Rossing MA; Schildkraut JM; Sellers TA; Singer CF; Song H; Stram DO; Sutphen R; Lindblom A; ; Terry KL; Tsai YY; van Altena AM; Vergote I; Vierkant RA; Vitonis AF; Walsh C; Wang-Gohrke S; Wappenschmidt B; Wu AH; Ziogas A; Berchuck A; Risch HA;
    Clin Cancer Res; 2011 Jun; 17(11):3742-50. PubMed ID: 21385923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.
    Hollestelle A; Pelletier C; Hooning M; Crepin E; Schutte M; Look M; Collee JM; Nieuwlaat A; Dorssers LC; Seynaeve C; Aulchenko YS; Martens JW; van den Ouweland AM; Weidhaas JB
    Breast Cancer Res Treat; 2011 Jul; 128(1):79-84. PubMed ID: 20676756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population.
    Uvirova M; Simova J; Kubova B; Dvorackova N; Tomaskova H; Sedivcova M; Dite P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):466-71. PubMed ID: 26077004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of interleukin 10 rs1800896 polymorphism with susceptibility to breast cancer: a meta-analysis.
    Zhu Z; Liu JB; Liu X; Qian L
    J Int Med Res; 2020 Apr; 48(4):300060520904863. PubMed ID: 32349574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis reveals PTPN22 1858C/T polymorphism confers susceptibility to rheumatoid arthritis in Caucasian but not in Asian population.
    Nabi G; Akhter N; Wahid M; Bhatia K; Mandal RK; Dar SA; Jawed A; Haque S
    Autoimmunity; 2016; 49(3):197-210. PubMed ID: 26763276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMP-2 G-418C polymorphism and cancer risk: A meta-analysis.
    Zhang S; Gao X; Yang J; Ji Z
    J Cancer Res Ther; 2015; 11(2):308-12. PubMed ID: 26148591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of rs2233678 and rs2233679 polymorphisms in the PIN1 gene with cancer risk: a meta-analysis.
    Zhenzhen L; Ning S; Xianghua L
    Tumour Biol; 2014 Jan; 35(1):433-40. PubMed ID: 23982872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levels.
    Crowley EH; Arena S; Lamba S; Di Nicolantonio F; Bardelli A
    Hum Mutat; 2014 Feb; 35(2):208-14. PubMed ID: 24282149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of rs712 polymorphism in Kras gene 3'-luntranslated region and cancer risk: a meta-analysis.
    Zhao WH; Qu XF; Xing ZG; Zhao LQ; Qin L; Lv C
    J BUON; 2015; 20(1):309-16. PubMed ID: 25778332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Rs61764370 polymorphism within let-7 microRNA-binding site with lung cancer in Iranian population.
    Farokhzad N; Hosseini SM; Edalat H; Sadeghi M
    Afr Health Sci; 2020 Sep; 20(3):1299-1303. PubMed ID: 33402978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between polymorphisms of the ADIPOQ gene and hypertension risk: a systematic and meta-analysis.
    Fan W; Qu X; Li J; Wang X; Bai Y; Cao Q; Ma L; Zhou X; Zhu W; Liu W; Ma Q
    Sci Rep; 2017 Feb; 7():41683. PubMed ID: 28181566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rs61764370 Functional Variant in the KRAS Oncogene is Associated with Chronic Myeloid Leukemia Risk in Women.
    Gutiérrez-Malacatt H; Ayala-Sanchez M; Aquino-Ortega X; Dominguez-Rodriguez J; Martinez-Tovar A; Olarte-Carrillo I; Martinez-Hernandez A; C CC; Orozco L; Cordova EJ
    Asian Pac J Cancer Prev; 2016; 17(4):2265-70. PubMed ID: 27221928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis.
    Liu J; Zheng Y; Lei D; Liu D; Xu F; Jin T; Cao X; Zhao X; Yu X; Pan X
    Asian Pac J Cancer Prev; 2011; 12(8):1899-903. PubMed ID: 22292622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.
    Kazmi HR; Chandra A; Kumar S; Satyam LK; Gupta A; Nigam J; Srivastava M; Mittal B
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2577-2583. PubMed ID: 27620744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.